About this trial
This is a single-site observational study designed to evaluate the efficacy of Lacrifill™ canalicular filler in optimizing ocular surface parameters and biometric precision in prospective cataract surgery patients with dry eye disease (DED).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age >= 40 years
Diagnosed dry eye (OSDI >= 13, TBUT < 10 sec, or Oxford staining >= Grade 2)
No recent ocular surgeries (<6 months)
No significant changes in DED regimen within last 1 month
Disqualifiers
Previous punctal plugs or canalicular cautery
Active ocular inflammation or corneal pathology unrelated to DED
Trial population
Subjects aged 40 years or older with diagnosed dry eye disease, totaling 65 eyes enrolled.
Trial design
Cohort
Prospective
Treatments tested in this trial
Lacrifill Canalicular Filler
DeviceLacrifill Canalicular Filler
Treatment groups
Trial outcomes
Primary outcomes
Mean absolute error (MAE)
Difference in mean spherical equivalent Mean Absolute Error (MAE) between actual postoperative manifest refraction spherical equivalent and back-calculated equivalent based on baseline biometry.
Secondary outcomes
Difference in mean magnitude of postoperative refractive astigmatism
Lens type candidacy
Evaluation of patient eligibility for IOL based on improved ocular surface conditions and investigator medical judgement.
Postoperative uncorrected visual acuity (logMAR)
Subjective visual satisfaction
National Eye Institute Visual Functioning Questionnaire 25 (VFQ-25). Graded on a scale from 1 to 5 with lower scores indicative of higher satisfaction.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
The Eye Institute of West Florida
Lead sponsor
Sengi
Collaborator